Cannara Biotech, Inc. · TSX:LOVE

Cannara Biotech — Q3 2026 Earnings Presentation

23 slides from Cannara Biotech's earnings presentation, Jul 15, 2026

  1. Slide 1: Premium-Quality Cannabis at Scale

    TSX: LOVE | OTCQX: LOVFF | FRA: 8CB0 PREMIUM-QUALITY CANNABIS AT SCALE INVESTOR DECK July 2026

  2. Slide 2: General Disclosures

    General Disclosures Disclaimer This presentation is qualified in its entirety by reference to, and must be read in conjunction with, the information contained in the Company’s most recent Annual Information Form, as well as in the Company’s most recent consolidated financial statements, together wit

  3. Slide 3: Forward-Looking Statements

    General Disclosures Forward-Looking Statements This presentation may contain “forward-looking information” within the meaning of Canadian securities legislation (“forward-looking statements”). These forward-looking statements are made as of the date of this presentation and the Company does not inte

  4. Slide 4: Cannara: One LOVE

    Cannara: One LOVE One of Canada’s Fastest Growing Top-10 Licensed Producers*. Scalable. Profitable. Proudly Cannara 3 Flagship Brands Scaled Capacity 450+ >58,000 kg Overview Team members Financials HQ: Montreal, Canada Current annualized production Assets Grow: Farnham & Valleyfield with owned high

  5. Slide 5: Recent Milestones & Execution Milestones

    Recent Milestones & Execution Milestones MEDICAN Overview ORGANIC Financials Assets March 2026 May 2026 July 2026 July 2026 Strategy Cannara graduates to Cannara announces Cannara secures exclusive Cannara enters long-term Performance Toronto Stock Exchange completed acquisition of Canadian rights t

  6. Slide 6: Our Three Pillars

    Our Three Pillars A repeatable operating system built for profitable growth Market Discipline SKU discipline + category focus Current >58,000 kg annualized Overview Financials production Assets Strategy Velocity + inventory turns $30M CAPEX plan over 3 years to Performance reach 100,000 kg annualize

  7. Slide 7: Profitability Sets Us Apart

    Profitability Sets Us Apart Q3 2026 Q3 2025 Variance Q3 2026 YTD Q3 2025 YTD Variance $45.1M $38.8M +$6.3M $126.7M $112.4M +$14.3M $44.1M $37.8M +$6.2M $123.7M $109.5M +$14.2M $1.01M $0.97M +$0.04M $3.0M $2.9M +$0.1M Overview $31.8M $27.3M +$4.5M $89.1M $79.0M +$10.1M Financials Assets $13.4M $12.1M

  8. Slide 8: Well Capitalized Balance Sheet

    Well Capitalized Balance Sheet Selected Financial Highlights As at May 31, 2026 As at August 31, 2025 Variance ($) Cash $21.8M $14.4M $7.4M Accounts receivable $18.5M $14.1M $4.4M Biological assets $6.0M $6.8M ($0.8M) Inventory $49.6M $44.5M $5.1M Overview Financials Assets Working capital1 $65.1M $

  9. Slide 9: Scaling Sales

    Scaling Sales Cannabis Revenue Growth Trajectory as Valleyfield Production Scales Up Cannabis NET Revenue in $ Millions Gross Profit Before Fair Value Adjustment % Gross Margin $31.8 $30.1 100% $28.3 Overview $27.3 $27.2 90% $26.6 Financials $24.0 80% Assets $22.1 70% Strategy $18.5 $18.8 $18.3 Perf

  10. Slide 10: Two Quebec Based Mega Facilities: Valleyfield

    Two Quebec Based Mega Facilities Valleyfield: 1M sq. ft., 24 independent grow rooms, each 25,000 sq. ft. Overview Financials Assets Strategy Performance Fact Sheet Leadership Each activated zone has been designed to replicate indoor growing conditions eliminating variability and maximizing Summary V

  11. Slide 11: Two Quebec Based Mega Facilities: Farnham

    Two Quebec Based Mega Facilities Farnham: 605,000 sq. ft., 170, 000 sq. ft. of cannabis operations Overview Financials Assets Strategy Performance Fact Sheet Leadership Summary Farnham Facility • 605,000 sq. ft. facility provides 170,000 sq. ft. of cannabis operations. • Pre-roll manufacturing centr

  12. Slide 12: Disciplined Growth & Expansion

    Disciplined Growth & Expansion Cannara’s Estimated Fiscal Year End Production Capacity in kg Owned capacity 120,000 expansion advanced by 1-year to meet demand 100,000 100,000 100,000 Annualized Production (kg) 88,000 Overview 80,000 75,000 88,000 Financials Assets 75,000 Strategy 58,000 60,000 Tota

  13. Slide 13: Capital Deployment & ROI Guardrails

    Capital Deployment & ROI Guardrails Phased activation with ROI discipline, aligned to demand What We Fund How We Pace Growth ROI Guardrails Post-processing (gating item) Modest incremental capex per room Unlocks throughput + quality Demand-led activations (activation, not construction) Overview cons

  14. Slide 14: Canadian Recreational Cannabis Market

    Canadian Recreational Cannabis Market Continued year-over-year growth, record R12M retail sales in April 2026 of $5.72B (+4.7%) Rolling 12-Month Retail Sales of Legal Cannabis Stores in Canada from November 2022 to April 2026 6,000,000 R12M Retail Sales (CDN $, x1000) 5,800,000 Overview 5,600,000 Fi

  15. Slide 15: Why Quebec

    Why Quebec Average Electricity Rates By Province In Cents Per Kw Hour Quebec has one of the lowest electricity rates in Canada QC MB BC SK ON AB NS 6.6¢/kWh 7.0¢/kWh 9.4¢/kWh 11.2¢/kWh 12.7¢/kWh 13.7¢/kWh 14.8¢/kWh Overview Financials Assets Quebec has the highest barriers Strategy 629 671 247 175 o

  16. Slide 16: Competitive Advantage

    Competitive Advantage Price Community Innovation & Scalable Quality Competitiveness Customer Loyalty Engagement Rare Genetics Premium, craft-style Value-based pricing Consistent repeatable Direct engagement Continuous innovation quality delivered at enabled by Quebec’s experiences with a with consum

  17. Slide 17: Increasing Our Market Share

    Increasing Our Market Share Estimated Retail Market Growth1 Market June 2026 Q3 2026 Q2 2026 Q1 2026 FY 2025 FY 2024 National 4.4% 4.4% 4.4% 4.1% 3.8% 2.9% QC 12.9% 14.1% 14.3% 13.5% 12.7% 8.3% ON 3.7% 3.5% 3.1% 3.1% 2.8% 2.7% Overview AB 2.9% 2.6% 2.3% 2.5% 2.5% 1.9% Financials Assets BC 2.1% 1.7%

  18. Slide 18: A National Revenue Base

    A National Revenue Base 54% of Cannara’s Canadian Cannabis Retail Sales Outside Québec Cannara Q3 2026 Revenue by Province SK AB Overview BC Financials 11% Assets Strategy 6% MB Performance Fact Sheet NS Leadership QC 46% Summary 34% ON Québec 46% | Ontario 34% | Alberta 11% | British Columbia 6% |

  19. Slide 19: Brand & Product Portfolio Leadership

    Brand & Product Portfolio Leadership Overview Financials Assets Strategy Performance Fact Sheet Leadership Summary Canada’s #1 Canada’s #1 Canada’s #1 Canada’s #1 Hash rosin Mass premium 3.5g Premium Live resin CBD flower brand flower brand vape brand brand July 2026 19 Based on retail market sales

  20. Slide 20: Executive Leadership Team

    Executive Leadership Team Zohar is an entrepreneur who has Nicholas Sosiak, CPA, is the Avi has been in the information launched several successful businesses. He dynamic and hands-on executive technology industry for over 20 has founded, advised and invested in of Cannara Biotech, passionately year

  21. Slide 21: Executive Leadership Team

    Executive Leadership Team ZOHAR KRIVOROT DONALD OLDS CHAIRMAN & CEO LEAD DIRECTOR & CHAIRMAN OF THE AUDIT Zohar is a seasoned entrepreneur who has built & GOVERNANCE COMMITTEE and grown multiple successful businesses. He has Donald Olds is an experienced life played pivotal roles as a founder, advis

  22. Slide 22: Strategy Backed by Results

    Strategy Backed by Results Premium quality at scale, delivered at disruptive prices, enabled by disciplined execution STRATEGY EXECUTION RESULTS Premium Vertical #1 Overview LEADERSHIP Quality Integration in Quebec Financials Assets Strategy Performance Disruptive Operational Profitable Fact Sheet P

  23. Slide 23: Thank You

    TSX: LOVE | OTCQX: LOVFF | FRA: 8CB0 THANK YOU Overview Financials www.cannara.ca Assets Strategy investors.cannara.ca Performance Fact Sheet www.instagram.com/cannarabiotech Leadership Summary www.facebook.com/cannarabiotech CANNARA HEADQUARTERS FARNHAM FACILITY VALLEYFIELD FACILITY 333 Decarie blv

Cannara Biotech — Q3 2026 Earnings Presentation on 6ix